Skip to main content
  1. Home

Renal

Renal

The Renal Standing Committee oversees the consensus based entity's portfolio of renal measures, which includes measures for hemodialysis, standardized mortality and transfusion ratios, phosphorus concentration, hypercalcemia, pediatric hemodialysis, Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker therapy, optimal end stage renal disease starts, and bloodstream infections in hemodialysis patients.

Vascular Access—Functional Arteriovenous Fistula (AVF) or AV Graft or Evaluation for Placement

Percentage of end stage renal disease (ESRD) patients aged 18 years and older receiving hemodialysis during the 12-month reporting period and on dialysis >90 days who:

1. have a functional autogenous AVF (defined as two needles used or a single-needle device [NOT one needle used in a two-needle device]) (computed and reported separately);

2. have a functional AV graft (computed and reported separately); or

CBE ID
0251